Efficacy of Phytochemicals Derived from Avicennia officinalis for the Management of COVID-19: A Combined In Silico and Biochemical Study
- PMID: 33921289
- PMCID: PMC8070553
- DOI: 10.3390/molecules26082210
Efficacy of Phytochemicals Derived from Avicennia officinalis for the Management of COVID-19: A Combined In Silico and Biochemical Study
Abstract
The recent coronavirus disease 2019 (COVID-19) pandemic is a global threat for healthcare management and the economic system, and effective treatments against the pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus responsible for this disease have not yet progressed beyond the developmental phases. As drug refinement and vaccine progression require enormously broad investments of time, alternative strategies are urgently needed. In this study, we examined phytochemicals extracted from Avicennia officinalis and evaluated their potential effects against the main protease of SARS-CoV-2. The antioxidant activities of A. officinalis leaf and fruit extracts at 150 µg/mL were 95.97% and 92.48%, respectively. Furthermore, both extracts displayed low cytotoxicity levels against Artemia salina. The gas chromatography-mass spectroscopy analysis confirmed the identifies of 75 phytochemicals from both extracts, and four potent compounds, triacontane, hexacosane, methyl linoleate, and methyl palminoleate, had binding free energy values of -6.75, -6.7, -6.3, and -6.3 Kcal/mol, respectively, in complexes with the SARS-CoV-2 main protease. The active residues Cys145, Met165, Glu166, Gln189, and Arg188 in the main protease formed non-bonded interactions with the screened compounds. The root-mean-square difference (RMSD), root-mean-square fluctuations (RMSF), radius of gyration (Rg), solvent-accessible surface area (SASA), and hydrogen bond data from a molecular dynamics simulation study confirmed the docked complexes' binding rigidity in the atomistic simulated environment. However, this study's findings require in vitro and in vivo validation to ensure the possible inhibitory effects and pharmacological efficacy of the identified compounds.
Keywords: Avicennia officinalis; GC-MS; SARS-CoV-2; antioxidant; main protease; molecular dynamics simulation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070553/bin/molecules-26-02210-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070553/bin/molecules-26-02210-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070553/bin/molecules-26-02210-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070553/bin/molecules-26-02210-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070553/bin/molecules-26-02210-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070553/bin/molecules-26-02210-g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070553/bin/molecules-26-02210-g007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070553/bin/molecules-26-02210-g008.gif)
![Figure 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070553/bin/molecules-26-02210-g009.gif)
![Figure 10](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070553/bin/molecules-26-02210-g010.gif)
Similar articles
-
Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (Mpro) using molecular docking and deep learning methods.Comput Biol Med. 2023 May;157:106785. doi: 10.1016/j.compbiomed.2023.106785. Epub 2023 Mar 11. Comput Biol Med. 2023. PMID: 36931201 Free PMC article.
-
Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach.PLoS One. 2022 Aug 23;17(8):e0273341. doi: 10.1371/journal.pone.0273341. eCollection 2022. PLoS One. 2022. PMID: 35998194 Free PMC article.
-
Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis.Medicina (Kaunas). 2021 Dec 23;58(1):20. doi: 10.3390/medicina58010020. Medicina (Kaunas). 2021. PMID: 35056328 Free PMC article. Review.
-
Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations.Biomed Res Int. 2021 Oct 4;2021:1636816. doi: 10.1155/2021/1636816. eCollection 2021. Biomed Res Int. 2021. PMID: 34646882 Free PMC article. Review.
-
Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.Int J Mol Sci. 2021 Aug 30;22(17):9431. doi: 10.3390/ijms22179431. Int J Mol Sci. 2021. PMID: 34502340 Free PMC article.
Cited by
-
An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).Heliyon. 2024 Feb 9;10(4):e25837. doi: 10.1016/j.heliyon.2024.e25837. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38379969 Free PMC article.
-
Network Pharmacology Integrated Molecular Docking and Dynamics to Elucidate Saffron Compounds Targeting Human COX-2 Protein.Medicina (Kaunas). 2023 Nov 22;59(12):2058. doi: 10.3390/medicina59122058. Medicina (Kaunas). 2023. PMID: 38138161 Free PMC article.
-
Effects of gamma-radiation on microbial, nutritional, and functional properties of Katimon mango peels: A combined biochemical and in silico studies.Heliyon. 2023 Oct 31;9(11):e21556. doi: 10.1016/j.heliyon.2023.e21556. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027912 Free PMC article.
-
Probiotic potential of Lactobacillus plantarum DMR14 for preserving and extending shelf life of fruits and fruit juice.Heliyon. 2023 Jun 19;9(6):e17382. doi: 10.1016/j.heliyon.2023.e17382. eCollection 2023 Jun. Heliyon. 2023. PMID: 37484375 Free PMC article.
-
Drug target of natural products and COVID-19: how far has science progressed?Ann Med Surg (Lond). 2023 Apr 19;85(6):2731-2742. doi: 10.1097/MS9.0000000000000703. eCollection 2023 Jun. Ann Med Surg (Lond). 2023. PMID: 37363478 Free PMC article.
References
-
- Zhu L., Yang P., Zhao Y., Zhuang Z., Wang Z., Song R., Zhang J., Liu C., Gao Q., Xu Q., et al. Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients. Immunity. 2020;53:685–696. doi: 10.1016/j.immuni.2020.07.009. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous